Stonepine Capital Management, LLC - CATABASIS PHARMACEUTICALS IN ownership

CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 30 filers reported holding CATABASIS PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Stonepine Capital Management, LLC ownership history of CATABASIS PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2018$182,00041,6880.16%
Other shareholders

There were no reported owners of CATABASIS PHARMACEUTICALS IN in Q1 2019.

NameSharesValueWeighting ↓
View complete list of CATABASIS PHARMACEUTICALS IN shareholders